Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SuliXen
- Development stage
- Preclinical
- Lead developer
- Xenetic Biosciences
- Modality
- Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Subcutaneous
01
Overview
SuliXen is a proprietary long-acting insulin formulation developed using Lipoxen’s (now Xenetic Biosciences’) polymer-based drug delivery technology, designed to provide sustained basal insulin activity for the treatment of type 1 and type 2 diabetes. It incorporates insulin into a biodegradable or otherwise modified carrier matrix intended to prolong circulation time and reduce injection frequency compared with conventional insulin preparations, with development initially focused on preclinical evaluation in diabetic animal models. By extending insulin’s duration of action while preserving its glucose-lowering properties via insulin receptor activation, SuliXen aims to improve glycemic control and patient adherence relative to standard insulin therapies.[8][12]
- Brand names
- SuliXen
02
Targets
INSR (Insulin receptor)
Beyond the preview
Go deeper on SuliXen.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SuliXen.